Ugur Sahin, CEO of BioNTech, sees a need for an updated Covid-19 vaccine by middle of next year as the virus further mutates.

BioNTech, together with Pfizer, developed what has been described as the first vaccine late last year.

“This year [a different vaccine] is completely unneeded. But by mid next year, it could be a different situation,” said Sahin in an interview with the Financial Times.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook